Mahesh Krishnan, Director of Halozyme Therapeutics HALO, has filed 0 purchases and 2 sales on the open market. Over the past 12 months that comes to a net sale of $547.8K. The latest trade was on 06/29.

MK

MK

Mahesh Krishnan

Director

Company

Halozyme Therapeutics HALO

First filing

23/04/04

Trades

15 trades

Buys / sales

0 / 2

12-month net buying

−$547.8K

Last trade

06/29

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Halozyme TherapeuticsHALO	Open-market sale10b5-1 plan	06/29	06/30	7,304 sh	$75.00	$547,800	−33.6%
CT Chinook Therapeutics	Open-market sale10b5-1 plan	23/04/04	23/04/04	924 sh	$23.01	$21,261.24	−42.0%